摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(sulfooxy)ursodeoxycholic acid | 74723-14-1

中文名称
——
中文别名
——
英文名称
7-(sulfooxy)ursodeoxycholic acid
英文别名
3α-hydroxy-7β-sulfooxy-5β-cholane-24-oic acid;(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
7-(sulfooxy)ursodeoxycholic acid化学式
CAS
74723-14-1
化学式
C24H40O7S
mdl
——
分子量
472.643
InChiKey
DPVCTIYTPXYDMQ-UZVSRGJWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.28±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.96
  • 拓扑面积:
    130
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    熊去氧胆酸吡啶三氧化硫吡啶 作用下, 反应 0.17h, 以4.1%的产率得到7-hydroxy-3-(sulfooxy)-(3α,5β,7β)-cholan-24-oic acid
    参考文献:
    名称:
    Bandiera, Tiziano; Albini, Franca Marione; Albini, Enrico, Synthetic Communications, 1987, vol. 17, # 9, p. 1111 - 1118
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Composition and therapies for hyperlipidaemia-associated disorders
    申请人:——
    公开号:US20040009961A1
    公开(公告)日:2004-01-15
    The invention relates to pharmaceutical compositions comprising at least one fibrate and at least one bile acid, and to methods for the treatment of hyperlipidaemia or elevated liver function tests in a patient by administering at least one fibrate and at least one bile acid to the patient.
    本发明涉及包含至少一种纤维酸盐和至少一种胆汁酸的药物组合物,以及通过向患者施用至少一种纤维酸盐和至少一种胆汁酸来治疗患者高脂血症或肝功能检测升高的方法。
  • EP1284723A4
    申请人:——
    公开号:EP1284723A4
    公开(公告)日:2004-06-30
  • COMPOSITIONS AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS
    申请人:Borody, Thomas, Julius
    公开号:EP1284723A1
    公开(公告)日:2003-02-26
  • COMPOSITION AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS
    申请人:BORODY THOMAS JULIUS
    公开号:US20080286354A1
    公开(公告)日:2008-11-20
    The invention relates to pharmaceutical compositions comprising at least one fibrate and at least one bile acid, and to methods for the treatment of hyperlipidaemia or elevated liver function tests in a patient by administering at least one fibrate and at least one bile acid to the patient.
  • [EN] COMPOSITIONS AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS<br/>[FR] COMPOSITIONS ET METHODES POUR TRAITER DES TROUBLES ASSOCIES A L'HYPERLIPIDEMIE
    申请人:BORODY THOMAS J
    公开号:WO2001080852A1
    公开(公告)日:2001-11-01
    The invention relates to pharmaceutical compositions comprising at least one fibrate and at least one bile acid, and to methods for the treatment of hyperlipidaemia or elevated liver function tests in a patient by administering at least one fibrate and at least one bile acid to the patient.
查看更多